- Home
- MVO vs HLVX Comparison
MVO vs HLVX Comparison
Compare MVO & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVO
- HLVX
- Stock Information
- Founded
- MVO 2006
- HLVX 2020
- Country
- MVO United States
- HLVX United States
- Employees
- MVO N/A
- HLVX N/A
- Industry
- MVO Oil & Gas Production
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- MVO Energy
- HLVX Health Care
- Exchange
- MVO Nasdaq
- HLVX Nasdaq
- Market Cap
- MVO 95.7M
- HLVX 83.7M
- IPO Year
- MVO N/A
- HLVX 2022
- Fundamental
- Price
- MVO $5.98
- HLVX $1.69
- Analyst Decision
- MVO
- HLVX Hold
- Analyst Count
- MVO 0
- HLVX 5
- Target Price
- MVO N/A
- HLVX $2.33
- AVG Volume (30 Days)
- MVO 55.1K
- HLVX 273.4K
- Earning Date
- MVO 01-01-0001
- HLVX 05-08-2025
- Dividend Yield
- MVO 17.46%
- HLVX N/A
- EPS Growth
- MVO N/A
- HLVX N/A
- EPS
- MVO 1.46
- HLVX N/A
- Revenue
- MVO N/A
- HLVX N/A
- Revenue This Year
- MVO N/A
- HLVX N/A
- Revenue Next Year
- MVO N/A
- HLVX N/A
- P/E Ratio
- MVO $7.29
- HLVX N/A
- Revenue Growth
- MVO N/A
- HLVX N/A
- 52 Week Low
- MVO $8.85
- HLVX $1.34
- 52 Week High
- MVO $13.95
- HLVX $16.31
- Technical
- Relative Strength Index (RSI)
- MVO 55.09
- HLVX 55.97
- Support Level
- MVO $5.52
- HLVX $1.62
- Resistance Level
- MVO $6.09
- HLVX $1.75
- Average True Range (ATR)
- MVO 0.40
- HLVX 0.12
- MACD
- MVO 0.05
- HLVX 0.03
- Stochastic Oscillator
- MVO 73.33
- HLVX 85.37
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These oil and gas properties include producing oil and gas wells.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.